StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMNov 20, 2026, 05:16 PM

HCW Biologics Adjourns Meeting, Reschedules for Jan 2027

AI Summary

HCW Biologics Inc. has adjourned its November 2026 Special Meeting of Stockholders due to a lack of quorum. The meeting has been rescheduled for January 26, 2027, with a record date of December 15, 2026. Two proposals will be presented: one to approve the issuance of shares upon exercise of common stock warrants from a July 2026 private placement, and another to approve the issuance of shares upon exercise of warrants from a September 2026 private placement, both as required by Nasdaq Listing Rule 5635(d). A definitive proxy statement is expected to be filed around December 17, 2026.

Key Highlights

  • HCW Biologics adjourned its November 2026 Special Meeting of Stockholders due to lack of quorum.
  • A new Special Meeting of Stockholders is scheduled for January 26, 2027.
  • Two proposals will be submitted for stockholder approval at the January 2027 meeting.
  • The proposals concern the approval of share issuances upon exercise of common stock warrants from July and September 2026 private placements.
  • Approval is required by Nasdaq Listing Rule 5635(d) for both warrant issuances.